The Global Allergy
Diagnostics And Therapeutics Market is anticipated to grow at a CAGR
exceeding 12% during the forecast period (2016 to 2022). This attributes to the
problem of environmental pollution and high incidence of allergic diseases. The
probability of children below 14 years of age being afflicted with chronic
allergies is a prominent factor that fuels industry demand. Frequent need for
in-vitro blood tests may drive this market over the forecast period. Widespread
adoption of diagnostics for treating inhaled allergies caused by air pollution
could significantly contribute to demand. Nowadays, people are highly
susceptible to allergies because of changing lifestyles, unhealthy dietary
patterns, and urbanization.
The worldwide allergy diagnostics and
therapeutics market is categorized on the basis of products, type of allergens,
end uses, tests, drug classes, and geographies. On the basis of products, the
segments are services, consumables, and instruments. Immunoassay analyzers,
luminometers, and other diagnostic devices are few of the commonly used
equipment. Popularity of immunoassay analyzers is by far the highest in most
developing economies of the world.
Browse Details of Report@
Various types of allergens are drug
allergens, inhaled allergens, food allergens, and others. Inhaled allergens
held the highest industry share over the past couple of years because of
numerous cases of air pollution based allergies.
Based on end uses, the industry is
trifurcated into diagnostics laboratories, and academic research institutes.
Types of tests mainly include the following: in-vitro, patch, intradermal, skin
prick, and in vivo. As per drug classes, the divisions are immunotherapy,
autoinjectable epinephrine, immunomodulators, decongestants, nasal
anticholinergics, leukotriene inhibitors, mast cell stabilizers,
corticosteroids, and antihistamines.
Geographically, the worldwide allergy
diagnostics and therapeutics market is divided into Asia Pacific, Europe, North
America, Latin America, and the Middle East & Africa. Over the past couple
of years, North America has been dominating the global market in terms of
revenue earnings. The region may continue leading the industry over the
forecast period. Growing acceptance of in vitro blood tests, awareness about
allergy diagnostics, and rising cases of allergic respiratory anomalies are
drivers of this region.
Europe is expected to register a high rate of
growth because the region boasts of a mature pharmaceuticals industry. Surging
demand for therapeutics is also a prominent regional driver. Other factors are
rising cases allergic conditions and a rapidly expanding geriatric population.
Asia Pacific may expand rapidly till 2022 owing to a rapidly developing medical
infrastructure and surging demand for minimally invasive diagnostics solutions.
The global allergy diagnostics and
therapeutics market is a highly fragmented one with a host of companies
continuously striving towards larger market shares. Lincoln Diagnostics,
Siemens Healthcare, Hitachi Chemical Diagnostics, Alcon Laboratories, and Hycor
Biomedical are some of the prominent competitors operating in the global
market.
In May 2016, Thermo Fisher Scientific
licensed ProBioGen AG’s GlymaxX® technology for the development of allergy
diagnostics. ProBioGen AG is a Germany based CDMO (contract development and
manufacturing organization) & technology provider. Its key areas of focus
are GMP production of biopharmaceuticals, process development, and cell lining
engineering. The GlymaxX® technology yields antibodies with lower fucose
content, is applicable to different types of species, needs no culture
additives, and can even lead to enhanced productivity.
Browse Related Category Market Reports@
About Us:
Hexa Research is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
No comments:
Post a Comment